Intravesical BCG Treatment for Superficial Bladder Cancer: Long‐term Results using Two Different Strains of BCG
- 1 February 1992
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 69 (2), 147-150
- https://doi.org/10.1111/j.1464-410x.1992.tb15486.x
Abstract
A total of 21 patients received intravesical BCG for the prevention of recurrence of superficial transitional cell carcinoma of the bladder. Twelve patients received the Glaxo strain and 9 the Pasteur strain of the bacillus. Although thought to have different anti‐tumour activities owing to a difference in antigenicity, these 2 strains produced similar tumour‐free rates at 5 years' mean follow‐up with an overall tumour‐free rate of 43%.Keywords
This publication has 13 references indexed in Scilit:
- Prospective Randomized Comparison of Intravesical with Percutaneous Bacillus Calmette-Guerin Versus Intravesical Bacillus Calmette-Guerin in Superficial Bladder CancerJournal of Urology, 1991
- Long-Term Results of Intravesical Bacillus Calmette-Guerin Therapy for Superficial Bladder CancerJournal of Urology, 1989
- Single Course Versus Maintenance Bacillus Calmette-Guerin Therapy for Superficial Bladder Tumors: A Prospective, Randomized TrialJournal of Urology, 1987
- Intravesical BCG Therapy in the Management of Multiple Superficial Bladder Carcinoma Comparison between Glaxo and Pasteur StrainsBJU International, 1987
- A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer.Journal of Clinical Oncology, 1987
- Long-Term Effect of Intravesical Bacillus Calmette-Guerin on Flat Carcinoma in Situ of the BladderJournal of Urology, 1986
- Bacillus Calmette-Guerin Immunotherapy for Bladder CancerJournal of Urology, 1985
- The Use of Bacillus Calmette-Guerin in the Therapy of Bladder Carcinoma in SituJournal of Urology, 1985
- Experience with Bacillus Calmette-Guerin in Patients with Superficial Bladder CarcinomaJournal of Urology, 1982
- ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1969